Bausch Health
327 hedge funds and large institutions have $1.97B invested in Bausch Health in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 109 increasing their positions, 103 reducing their positions, and 90 closing their positions.
60% more call options, than puts
Call options by funds: $145M | Put options by funds: $90.6M
6% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 103
4.66% less ownership
Funds ownership: 71.82% → 67.16% (-4.7%)
12% less funds holding
Funds holding: 370 → 327 (-43)
43% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 90
47% less funds holding in top 10
Funds holding in top 10: 17 → 9 (-8)
67% less capital invested
Capital invested by funds: $5.9B → $1.97B (-$3.93B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$101M |
| 2 |
GAM
Goldentree Asset Management
New York
|
+$85.3M |
| 3 |
D.E. Shaw & Co
New York
|
+$64.5M |
| 4 |
SCM
Segantii Capital Management
Hong Kong
|
+$58.7M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$56.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
-$212M |
| 2 |
GCC
Guardian Capital (Canada)
Toronto,
Ontario, Canada
|
-$88.8M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
-$70.2M |
| 4 |
CCA
Canyon Capital Advisors
Dallas,
Texas
|
-$59.4M |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
-$47.4M |
BHC Hedge Fund Activity: Q2 2022 in Review
327 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2022, worth a combined $1.97B — down 67% from $5.9B a quarter earlier.
Sellers outnumbered buyers: 90 funds closed out of BHC and 51 opened new positions — a net loss of 39 holders — while 103 trimmed existing stakes and 109 added.
The largest buyer was Franklin Resources, adding an estimated $101M. The largest seller was Glenview Capital Management, exiting entirely with an estimated $212M sold.
- 327 institutional investors held Bausch Health (BHC) as of Q2 2022, down from 370 in Q1 2022.
- Funds reported $1.97B of Bausch Health stock for Q2 2022, down 67% quarter-over-quarter.
- 51 funds opened new Bausch Health positions in Q2 2022 and 90 closed out, a net change of -39 holders.
- The largest Bausch Health buyer in Q2 2022 was Franklin Resources, an estimated $101M added.
- The largest Bausch Health seller in Q2 2022 was Glenview Capital Management, an estimated $212M sold.
Based on aggregated 13F filings for Q2 2022.